The role of magnetic resonance imaging-guided biopsy for diagnosis of prostate cancer; comparison between FUSION and 'IN-BORE' approaches
Autor: | Federico Mineo Bianchi, Angelo Porreca, Eugenio Brunocilla, Paolo Corsi, Walter Artibani, Cristian Fiori, Daniele Romagnoli, Carlo Casablanca, Marco Giampaoli, Daniele D'Agostino, Riccardo Schiavina |
---|---|
Rok vydání: | 2021 |
Předmět: |
Image-Guided Biopsy
Male Multivariate analysis Prostate biopsy Urology Magnetic resonance imaging guided biopsy Magnetic Resonance Imaging Interventional Prostate cancer Predictive Value of Tests Prostate Biopsy medicine Humans Aged Retrospective Studies medicine.diagnostic_test Index Lesion business.industry Prostatic Neoplasms Magnetic resonance imaging Middle Aged Prostate-Specific Antigen medicine.disease medicine.anatomical_structure Nephrology Neoplasm Grading Nuclear medicine business |
Zdroj: | Minerva Urology and Nephrology. 73 |
ISSN: | 2724-6442 2724-6051 |
DOI: | 10.23736/s2724-6051.20.03550-x |
Popis: | BACKGROUND The aim of the present study is to evaluate the difference in terms of feasibility and detection rate of two magnetic resonance imaging (MRI) guided biopsy approaches (MRI fusion versus "in-bore" MRI) in a single tertiary center. METHODS We retrospectively identified 297 patients with suspected prostate cancer who underwent MRI based target prostate biopsy (FUSION or "in-bore" approaches) between January 2016 and January 2018 in a single tertiary center. RESULTS Lesion site (peripheral vs. central) and localization (anterior vs. posterior) were equally comparable among two groups, but maximum diameter of multiparametric-MRI Index lesion was slightly superior in the in-bore MRI-GB group (14 vs. 12 mm, P=0.002). Mean random biopsy cores taken were 11.2±2.1, with 1.3±2 positive cores in FUSION-GB group. Mean number of targeted biopsy cores taken was significantly superior in the FUSION-GB group as compared to the in-bore MRI-GB group (2.6±0.7 vs.1.7±1, P |
Databáze: | OpenAIRE |
Externí odkaz: |